KRAS is the most frequently mutated oncogene in pancreatic cancer, and recent studies have verified that the activation of KRAS in cancer cells affects the properties and functions of the surrounding microenvironment (Dias Carvalho et al., 2018). The gene discussed is KRAS; the disease is pancreatic neoplasm.